HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

SHA:600829 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	745.67	1,100	1,314	1,181	800.49	418.7
Cash & Short-Term Investments	745.67	1,100	1,314	1,181	800.49	418.7
Cash Growth	-29.28%	-16.32%	11.25%	47.59%	91.18%	14.02%
Accounts Receivable	4,808	4,350	4,385	4,168	4,182	3,860
Other Receivables	17.92	53.13	64.96	47.26	40.91	4.04
Receivables	4,826	4,403	4,450	4,215	4,222	3,864
Inventory	1,047	1,101	1,115	1,074	1,105	1,123
Prepaid Expenses	-	9.98	1.79	4.59	8.44	-
Other Current Assets	109.5	72.83	42.8	71.01	48.78	129.95
Total Current Assets	6,729	6,687	6,925	6,546	6,185	5,536
Property, Plant & Equipment	326.2	335.85	346.13	367.81	410.84	312.43
Other Intangible Assets	27.72	28.08	26.5	28.01	29.29	26.59
Long-Term Deferred Tax Assets	69.6	67.45	67.69	64.25	67.15	65.24
Long-Term Deferred Charges	9.61	10.48	11.2	11.81	12.08	9.93
Other Long-Term Assets	36.83	37.42	50.3	40.54	43.14	45.16
Total Assets	7,199	7,166	7,426	7,059	6,748	5,995
Accounts Payable	2,830	2,781	2,914	2,614	2,478	2,671
Accrued Expenses	11.77	34.24	44.73	50.24	30.72	89.69
Short-Term Debt	780	839.22	962.08	1,198	1,233	610.7
Current Portion of Long-Term Debt	26.31	-	-	-	-	-
Current Portion of Leases	-	30.56	27.69	32.09	35.18	-
Current Income Taxes Payable	58.03	25.84	43.33	27.38	34.92	38.4
Current Unearned Revenue	8.38	15.12	15.99	11.45	13.3	12.33
Other Current Liabilities	409.64	408.3	512.7	498.47	531.72	440.44
Total Current Liabilities	4,125	4,134	4,521	4,431	4,357	3,863
Long-Term Leases	27.27	30.37	29.41	38.48	59.59	-
Long-Term Unearned Revenue	116.12	117.09	120.94	125.71	130.77	137.34
Long-Term Deferred Tax Liabilities	3.69	3.7	4.05	4.51	-	-
Other Long-Term Liabilities	-	-	0.14	0.57	1.56	2.58
Total Liabilities	4,272	4,285	4,675	4,601	4,549	4,003
Common Stock	579.89	579.89	579.89	579.89	579.89	579.89
Retained Earnings	2,347	2,301	2,172	1,879	1,620	1,413
Total Common Equity	2,927	2,881	2,751	2,459	2,200	1,993
Minority Interest	-0.04	-0.04	-0.04	-1.06	-1.02	-0.24
Shareholders' Equity	2,927	2,881	2,751	2,458	2,199	1,992
Total Liabilities & Equity	7,199	7,166	7,426	7,059	6,748	5,995
Total Debt	833.58	900.15	1,019	1,268	1,328	610.7
Net Cash (Debt)	-87.91	199.69	295.17	-86.9	-527.08	-191.99
Net Cash Growth	-	-32.35%	-	-	-	-
Net Cash Per Share	-0.15	0.34	0.51	-0.15	-0.91	-0.33
Filing Date Shares Outstanding	579.53	579.89	579.89	579.89	579.89	579.89
Total Common Shares Outstanding	579.53	579.89	579.89	579.89	579.89	579.89
Working Capital	2,604	2,553	2,404	2,115	1,829	1,673
Book Value Per Share	5.05	4.97	4.74	4.24	3.79	3.44
Tangible Book Value	2,899	2,853	2,725	2,431	2,171	1,966
Tangible Book Value Per Share	5.00	4.92	4.70	4.19	3.74	3.39
Buildings	-	372.04	372.04	374.91	374.93	376.61
Machinery	-	145.84	147.21	146.43	149.73	152.94
Construction In Progress	-	57.47	59.62	60.42	60.42	60.42

Updated Oct 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.